Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The interest coverage ratio is N/A as of Tuesday, October 6, 2026.
INTEREST COVERAGE RATIO
N/A
Market Cap
$5.95B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.93B
Interest Coverage Ratio
10.01x
TTM Avg
10.01x
3Y Avg
9.97x
5Y Avg
7.31x
Market Cap
$6.29B
Interest Coverage Ratio
-9.33x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.74B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.51B
Interest Coverage Ratio
15.74x
TTM Avg
19.48x
3Y Avg
15.56x
5Y Avg
15.56x
Market Cap
$6.51B
Interest Coverage Ratio
1.75x
TTM Avg
1.35x
3Y Avg
1.23x
5Y Avg
1.08x
Market Cap
$5.54B
Interest Coverage Ratio
1.30x
TTM Avg
1.31x
3Y Avg
1.26x
5Y Avg
1.25x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| GRAIL Inc. (GRAL) | $6.06B | N/A | N/A | N/A | N/A |
| Iovance Biotherapeutics, Inc. (IOVA)vs › | $5.95B | N/A | N/A | N/A | N/A |
| Ligand Pharmaceuticals Incorporated (LGND)vs › | $5.93B | 10.01x | 10.01x | 9.97x | 7.31x |
| Rhythm Pharmaceuticals, Inc. (RYTM)vs › | $6.29B | -9.33x | N/A | N/A | N/A |
| Kiniksa Pharmaceuticals International, plc (KNSA)vs › | $5.74B | N/A | N/A | N/A | N/A |
| CG Oncology Inc. (CGON)vs › | $5.71B | N/A | N/A | N/A | N/A |
| Lantheus Holdings, Inc. (LNTH)vs › | $6.51B | 15.74x | 19.48x | 15.56x | 15.56x |
| Amneal Pharmaceuticals, Inc. (AMRX)vs › | $6.51B | 1.75x | 1.35x | 1.23x | 1.08x |
| RadNet, Inc. (RDNT)vs › | $5.54B | 1.30x | 1.31x | 1.26x | 1.25x |
| Immunovant, Inc. (IMVT)vs › | $6.60B | N/A | N/A | N/A | N/A |
Interest Coverage
N/A
Debt/Equity
0.04
Current Ratio
10.95
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
